(EYPT) – Management Comments
-
EyePoint Pharmaceuticals (EYPT) Appoints Jay S. Duker, M.D. as Chief Operating Officer
-
EyePoint Pharmaceuticals (EYPT) Reports Positive 30-day Safety Results for all Cohorts from the DAVIO Trial of EYP-1901 for wet-AMD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EYPT Stock Lookup